ARS Pharmaceuticals, Inc. (SPRY)

Import this data to Google Sheets with:

=jivedata("SPRY","financials")

Full statements spill as a table. For one cell: =jivedata("SPRY","Revenue") or =jivedata("SPRY","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ARS Pharmaceuticals, Inc.

SPRY • CIK 0001671858

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$30	$89,149	$84,278	$116,927
Cost of Goods and Services Sold	—	$0	—	$0
Operating Expenses	$67,550	$92,232	$263,726	$333,194
Selling, General and Administrative Expense	$940	$71,675	$230,122	$284,489
Research and Development Expense	$20,266	$19,580	$13,181	$15,228
Operating Income (Loss)	$-67,520	$-3,083	$-179,448	$-216,267
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	$8,286	$-171,378	$-171,378
Income Tax Expense (Benefit)	$0	$288	$-80	$-80
Net Income (Loss) Attributable to Parent	$-54,365	$7,998	$-171,298	$-215,432

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$233,188	$351,153	$327,652	$249,495
Liabilities	$2,428	$94,355	$213,394	$236,983
Assets, Current	$231,726	$334,295	$284,896	$211,510
Cash and Cash Equivalents, at Carrying Value	$70,971	$50,817	$41,317	$8,163
Short-term Investments	$157,389	$263,205	$203,669	$135,682
Accounts Receivable, after Allowance for Credit Loss, Current	—	$8,175	$25,347	$46,839
Inventory, Net	—	$5,212	$31,422	$30,734
Property, Plant and Equipment, Net	$574	$1,029	$2,465	$2,085
Property, Plant and Equipment, Gross	$695	—	—	$748
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$121	$200	—	$200
Operating Lease, Right-of-Use Asset	$250	$37	—	$1,439
Intangible Assets, Net (Excluding Goodwill)	—	$7,371	$14,452	$13,900
Deferred Tax Assets, Net of Valuation Allowance	$29,156	$37,001	$73,800	$73,800
Liabilities, Current	$2,391	$23,440	$39,145	$60,863
Accounts Payable, Current	$759	$9,870	$5,725	$5,198
Stockholders' Equity Attributable to Parent	$230,760	$256,798	$114,258	$12,512

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Cash Provided by (Used in) Operating Activities	$-59,266	$13,548	$-170,866	$-196,405
Net Cash Provided by (Used in) Investing Activities	$-87,180	$-106,101	$56,768	$48,496
Net Cash Provided by (Used in) Financing Activities	$6,899	$72,399	$104,598	$104,532
Depreciation, Depletion and Amortization, Nonproduction	$100	$100	$1,367	$1,621
Payments to Acquire Property, Plant, and Equipment	$175	$563	$339	$197

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("SPRY","financials")

Full statements spill as a table. For one cell: =jivedata("SPRY","Revenue") or =jivedata("SPRY","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.